Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Am J Surg Pathol. 2019 Jul;43(7):920–927. doi: 10.1097/PAS.0000000000001264

Table 1.

Rates of PD-L1 expression in UCV using cutoff values to define positivity as 1% of TC (Table 1a) or 5% (Table 1b)

Table 1a SP263 SP142 22C3
Histologic differentiation (n) Tumors pos.* (n, %) TC (%; mean) TC (H-score, mean) IC (%; mean Tumors pos.* (n, %) TC (%; mean) TC (H-score, mean) IC (%; mean Tumors pos.* (n, %) TC (%; mean) TC (H-score, mean) IC (%; mean
Micropapillary (19) 13 (69%) 5 7 12 6 (32%) 2 4 5 7 (37%) 2 4 8
Squamous differentiation (16) 14 (88%) 42 86 12 14 (88%) 20 43 9 15 (94%) 30 50 14
Nested (14) 5 (36%) 4 7 10 1 (7%) 3 8 4 4 (29%) 4 7 8
Plasmacytoid (14) 5 (36%) 5 8 9 3 (21%) 1 1 3 2 (14%) 8 3 4
Small cell carcinoma (12) 2 (17%) 9 24 7 2 (17%) 7 19 3 2 (17%) 3 18 6
Glandular differentiation (9) 6 (67%) 6 9 14 5 (56%) 2 2 5 6 (67%) 9 4 10
Total (84) 45 (54%) 13 25 11 31 (37%) 6 13 5 36 (43%) 9 15 8
Table 1b SP263 SP142 22C3
Histologic differentiation (n) Tumors pos.* (n, %) TC (%; mean) TC (H-score, mean) IC (%; mean Tumors pos.* (n, %) TC (%; mean) TC (H-score, mean) IC (%; mean Tumors pos.* (n, %) TC (%; mean) TC (H-score, mean) IC (%; mean
Micropapillary (19) 6 (32%) 5 7 12 2 (11%) 2 4 5 3 (16%) 2 4 8
Squamous differentiation (16) 14 (88%) 42 86 12 13 (81%) 20 43 9 15 (94%) 30 50 14
Nested (14) 1 (7%) 4 7 10 1 (7%) 3 8 4 1 (7%) 4 7 8
Plasmacytoid (14) 3 (21%) 5 8 9 0 (0%) 1 1 3 2 (14%) 8 3 4
Small cell carcinoma (12) 2 (17%) 9 24 7 2 (17%) 7 19 3 2 (17%) 3 18 6
Glandular differentiation (9) 5 (56%) 6 9 14 1 (11%) 2 2 5 2 (22%) 9 4 10
Total (84) 31 (37%) 13 25 11 19 (23%) 6 13 5 25 (30%) 9 15 8

TC: Tumor cells, IC: immune cells